Patent · US Active

Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists

US7579340B2 · kind B2 · utility

3Cited by
8References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2007
Grant dateAug 25, 2009
Priority date
Expiry dateAug 22, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.